Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on HeraMED.
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
HeraMED gets set for Aussie clinical trials with new deal
Health & Biotech
HeraMED ramps up Australian strategy with new distribution deal
News
V-Con Recap: Here are the most important things we learned about the future of telehealth
Stockhead TV
Stockhead V-Con: The Future of TeleHealth
Health & Biotech
HeraMED scores major boost in the US market, following a landmark FDA ruling
News
Going Viral: All the best COVID-19 news from the week
Health & Biotech
StockDoc Podcast: HeraMED’s telehealth offering for pregnant women is booming under COVID-19
Stockhead TV
Stock Talk: TeleHealth in a COVID-19 world and beyond
News
Lunchtime ASX small cap wrap: Who’s ready for a stimulus package today?
Tech
